Search details
1.
Tucatinib promotes immune activation and synergizes with programmed cell death-1 and programmed cell death-ligand 1 inhibition in HER2-positive breast cancer.
J Natl Cancer Inst
; 115(7): 805-814, 2023 07 06.
Article
in English
| MEDLINE | ID: mdl-37166471
2.
Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer.
NPJ Breast Cancer
; 9(1): 68, 2023 Aug 15.
Article
in English
| MEDLINE | ID: mdl-37582853
3.
Intratumoral CD8+ T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer.
Cancer Cell
; 41(3): 585-601.e8, 2023 03 13.
Article
in English
| MEDLINE | ID: mdl-36827978
4.
Checkpoint inhibitor immunotherapy diminishes oocyte number and quality in mice.
Nat Cancer
; 3(8): 1-13, 2022 08.
Article
in English
| MEDLINE | ID: mdl-36008687
Results
1 -
4
de 4
1
Next >
>>